Recall Date: April 10, 2025
Recall number: 25-223
Recall Summary
Name of Product: Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
Hazard: The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
Remedy: Refund
Consumer Contact: Kramer Laboratories at 800-824-4894 Monday through Friday 8 a.m. to 5 p.m. ET, e-mail at kramerlabs@emersongroup.com, or online at https://safetussin.com/recall for more information.
Pictures available here: https://www.cpsc.gov/Recalls/2025/Kramer-Laboratories-Recalls-Safetussin-Max-Strength-Multi-Symptom-Cough-Cold-and-Flu-Blister-Packs-Due-to-Risk-of-Child-Poisoning-Violation-of-Federal-Regulation-for-Child-Resistant-Packaging
Recall Details
Units: About 14,250
Description: Description:
This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with “Safetussin,” “Multi-Symptom,” “Cough, Cold & Flu” and “Safe for adults with High Blood Pressure, Diabetes.” They were sold in a blue, orange and red cardboard box with the drug facts label on the back.
Remedy: Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.
Incidents/Injuries: None reported
Sold At: HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11.
Importer(s): Kramer Laboratories, of Bridgewater, New Jersey(a subsidiary of Arcadia Consumer Healthcare, of Bridgewater, New Jersey)
Manufactured In: India
Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.
